ADMERION Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for ADMERION with the United States Patent and Trademark Office. The USPTO has given the ADMERION trademark a serial number of 97272466. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2024. This trademark is owned by Astellas Pharma Inc.. The ADMERION trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing healthcare information

Providing a website featuring temporary use of non-downloadable software for obtaining healthcare information, finding physicians and personal coaches in the field of women's health, and ordering pharmaceuticals, vitamins, and pregnancy, ovulation prediction, and diabetes monitoring test kits for home use
admerion

General Information


Serial Number97272466
Word MarkADMERION
Filing DateThursday, February 17, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2022

Trademark Statements


Goods and ServicesProviding healthcare information
Goods and ServicesProviding a website featuring temporary use of non-downloadable software for obtaining healthcare information, finding physicians and personal coaches in the field of women's health, and ordering pharmaceuticals, vitamins, and pregnancy, ovulation prediction, and diabetes monitoring test kits for home use

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8411
JP

Trademark Events


Event DateEvent Description
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023SOU EXTENSION 2 GRANTED
Thursday, August 10, 2023SOU EXTENSION 2 FILED
Thursday, August 10, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 31, 2023SOU EXTENSION 1 GRANTED
Tuesday, January 31, 2023SOU EXTENSION 1 FILED
Tuesday, January 31, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 30, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, May 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2022NON-FINAL ACTION E-MAILED
Tuesday, April 19, 2022NON-FINAL ACTION WRITTEN
Sunday, April 17, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022NEW APPLICATION ENTERED